Cargando…
Epigenetic Mechanisms Involved in the Cardiovascular Toxicity of Anticancer Drugs
The cardiovascular toxicity of anticancer drugs promotes the development of cardiovascular diseases. Therefore, cardiovascular toxicity is an important safety issue that must be considered when developing medications and therapeutic applications to treat cancer. Among anticancer drugs, members of th...
Autores principales: | Papazoglou, Panagiota, Peng, Luying, Sachinidis, Agapios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110725/ https://www.ncbi.nlm.nih.gov/pubmed/33987212 http://dx.doi.org/10.3389/fcvm.2021.658900 |
Ejemplares similares
-
Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs
por: Sachinidis, Agapios
Publicado: (2020) -
Epigenetic mechanisms of Strip2 in differentiation of pluripotent stem cells
por: Srinivasan, Sureshkumar Perumal, et al.
Publicado: (2022) -
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
por: Morelli, Marco Bruno, et al.
Publicado: (2022) -
Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells
por: Cherianidou, Anna, et al.
Publicado: (2023) -
Editorial: Epigenetic Regulation in Cardiovascular Diseases
por: Pillai, Indulekha C. L., et al.
Publicado: (2022)